BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 8641363)

  • 1. The effects of human FLT3 ligand on in vitro human megakaryocytopoiesis.
    Piacibello W; Garetto L; Sanavio F; Severino A; Fubini L; Stacchini A; Dragonetti G; Aglietta M
    Exp Hematol; 1996 Feb; 24(2):340-6. PubMed ID: 8641363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant GM-CSF/IL-3 fusion protein: its effect on in vitro human megakaryocytopoiesis.
    Bruno E; Briddell RA; Cooper RJ; Brandt JE; Hoffman R
    Exp Hematol; 1992 May; 20(4):494-9. PubMed ID: 1373690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vitro and in vivo effects of stem cell factor on human hematopoiesis.
    Hoffman R; Tong J; Brandt J; Traycoff C; Bruno E; McGuire BW; Gordon MS; McNiece I; Srour EF
    Stem Cells; 1993 Jul; 11 Suppl 2():76-82. PubMed ID: 7691331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.
    Cardier JE; Erickson-Miller CL; Murphy MJ
    Stem Cells; 1997; 15(4):286-90. PubMed ID: 9253112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of c-kit ligand on in vitro human megakaryocytopoiesis.
    Briddell RA; Bruno E; Cooper RJ; Brandt JE; Hoffman R
    Blood; 1991 Dec; 78(11):2854-9. PubMed ID: 1720039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of haematopoietic progenitor development by FLT-3 ligand.
    Banu N; Deng B; Lyman SD; Avraham H
    Cytokine; 1999 Sep; 11(9):679-88. PubMed ID: 10479404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into the regulation of human megakaryocytopoiesis.
    Hoffman R; Straneva J; Yang HH; Bruno E; Brandt J
    Blood Cells; 1987; 13(1-2):75-86. PubMed ID: 3499196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+).
    Weimar IS; Miranda N; Muller EJ; Hekman A; Kerst JM; de Gast GC; Gerritsen WR
    Exp Hematol; 1998 Aug; 26(9):885-94. PubMed ID: 9694510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG
    Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-level effects of flt3 ligand on human hematopoiesis: expansion of putative stem cells and proliferation of granulomonocytic progenitors/monocytic precursors.
    Gabbianelli M; Pelosi E; Montesoro E; Valtieri M; Luchetti L; Samoggia P; Vitelli L; Barberi T; Testa U; Lyman S
    Blood; 1995 Sep; 86(5):1661-70. PubMed ID: 7544638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential. Suppression of apoptosis and counteraction by TNF-alpha and TGF-beta.
    Veiby OP; Jacobsen FW; Cui L; Lyman SD; Jacobsen SE
    J Immunol; 1996 Oct; 157(7):2953-60. PubMed ID: 8816402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo expansion of megakaryocyte precursors by preincubation of marrow allografts with interleukin-3 and granulocyte-macrophage colony-stimulating factor in vitro.
    Nagler A; Eldor A; Naparstek E; Mumcuoglu M; Slavin S; Deutsch VR
    Exp Hematol; 1995 Nov; 23(12):1268-74. PubMed ID: 7589281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Megakaryocytopoiesis in vitro: from the stem cells' perspective.
    Cardier JE; Foster DC; Lok S; Jacobsen SE; Murphy MJ
    Stem Cells; 1996; 14 Suppl 1():163-72. PubMed ID: 11012217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of thrombocytopoiesis-stimulating factor on terminal cytoplasmic maturation of human megakaryocytes.
    Straneva JE; Briddell RA; McDonald TP; Yang HH; Hoffman R
    Exp Hematol; 1989 Dec; 17(11):1122-7. PubMed ID: 2684680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro response of normal and aplastic anemia bone marrow to mast cell growth factor and in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3.
    Gibson FM; Scopes J; Daly S; Ball SE; Gordon-Smith EC
    Exp Hematol; 1994 Mar; 22(3):302-12. PubMed ID: 8112428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of retroviral-mediated gene transfer into primary human stromal cells of Flt3-ligand, interleukin 3 and GM-CSF on production of cord blood progenitor cells in long-term culture.
    Balduini A; Braun SE; Cornetta K; Lyman S; Broxmeyer HE
    Stem Cells; 1998; 16 Suppl 1():37-49. PubMed ID: 11012147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marrow-derived heparan sulfate proteoglycan mediates the adhesion of hematopoietic progenitor cells to cytokines.
    Bruno E; Luikart SD; Long MW; Hoffman R
    Exp Hematol; 1995 Oct; 23(11):1212-7. PubMed ID: 7556532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombopoiesis-stimulating factor: its effects on megakaryocyte colony formation in vitro and its relation to human granulocyte-macrophage colony-stimulating factor.
    Dessypris EN; Chuncharunee S; Frierson KE
    Exp Hematol; 1990 Aug; 18(7):754-7. PubMed ID: 2199204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flt 3 ligand, MGDF, Epo and G-CSF enhance ex vivo expansion of hematopoietic cell compartments in the presence of SCF, IL-3 and IL-6.
    Kobari L; Giarratana MC; Poloni A; Firat H; Labopin M; Gorin NC; Douay L
    Bone Marrow Transplant; 1998 Apr; 21(8):759-67. PubMed ID: 9603398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential role of FLT3 ligand in progenitor and primitive hematopoietic cell expansion.
    Poloni A; Douay L; Giarratana MC; Kobari L; Gorin NC; Olivieri A; Leoni P
    Boll Soc Ital Biol Sper; 1997; 73(3-4):55-62. PubMed ID: 9540233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.